Plain-language explanation.
Epidemiology is the study of the distribution and determinants of health and disease in populations. It is the core science of public health — telling us who gets sick, why, and what we can do about it. Every public health intervention rests on epidemiological evidence.
Core concepts and standard treatment.
Core epidemiology covers measures of disease frequency (incidence rate, prevalence, attack rate, mortality rate, case fatality rate), measures of association (relative risk — RR; odds ratio — OR; rate ratio; attributable risk — PAF), study designs (RCTs — gold standard; cohort studies — prospective/retrospective; case-control studies; cross-sectional surveys; ecological studies), bias (selection bias, information bias, recall bias — STROBE checklist), confounding (confounders, stratification, multivariable regression — logistic, Cox), and causality (Bradford Hill criteria, directed acyclic graphs — DAGs, Judea Pearl do-calculus).
Deeper theory, debates and edge cases.
Advanced epidemiology covers causal inference methods (instrumental variables — Mendelian randomisation; difference-in-differences; interrupted time series — ITS; propensity score matching; synthetic control method), meta-analysis and systematic review (PRISMA, Cochrane methodology — fixed vs random effects, I² heterogeneity, funnel plots, publication bias — Egger test, trim and fill), pharmacoepidemiology (drug safety — yellow card / FAERS; ISPE guidelines; active surveillance — CPRD, Clinical Practice Research Datalink), genetic epidemiology (GWAS — genome-wide association studies; population stratification; PRS — polygenic risk scores), and infectious disease epidemiology (reproductive number R₀ and Rₜ, serial interval, generation time, contact tracing efficiency).
How it is applied in practice.
At the senior epidemiologist and head of surveillance level, practitioners contribute to International Journal of Epidemiology and Epidemiology & Infection; lead SAGE and SPI-M-O advisory committees for epidemic response; design and analyse large-scale cohort studies (UK Biobank, ALSPAC, Whitehall II); contribute to IARC cancer classification working groups; run pharmacovigilance programmes (MHRA Yellow Card, EMA signal detection — EudraVigilance); and advise WHO, ECDC, and UKHSA on emerging infectious disease risk assessments.